NCT05671393
- Conditions
- Gastric Neuroendocrine Carcinoma
- Locations
-
- Chang-ming Huang Fuzhou, Fujian, China
Clinical trial condition
Gastric Neuroendocrine Carcinoma
Explore clinical trials studying Gastric Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Gastric Neuroendocrine Carcinoma trial results
Active, Not Recruiting
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
NCT02595424
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +19 more
- Locations
-
- Kingman Regional Medical Center Kingman, Arizona, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
- CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States